Stockreport
Biogen Announces Board Chair Transition
Last biogen inc. earnings: 4/22 07:12 am
Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
CAMBRIDGE, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the Board of Directors has elected Dr. Maria C. Freire as Chair of the Board of Directors, effective immediately following the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”), scheduled to take place on June 9, 2026. Dr. Freire will succeed Caroline Dorsa who has decided to retire from the Biogen Board of Directors and not to stand for reelection at the Annual Meeting. Dr. Freire joined the Biogen Board in 2021 and serves on the Corporate Governance Committee and on the Compensation and Management Development Committee. Ms. Dorsa said: “It has been an honor to serve on the Board of Biogen for the past sixteen years. I am proud of the groundbreaking science and innovative medicines the Company has pioneered. I want to extend my gratitude to Chris Viehbacher, Biogen's CEO, for his strong collaboration and partnership. Under Chris' leadership and renewed focus on va
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | BIIB | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
BIIB alerts
BIIB alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIIB alerts
High impacting Biogen Inc. news events
Weekly update
A roundup of the hottest topics
BIIB
NEWS
NEWS
- Biogen (NASDAQ:BIIB) was given a new $185.00 price target on by analysts at Barclays PLC.[MarketBeat]
- Wedbush Lifts PT on Biogen Inc. (BIIB) to $187 From $178 – Here's Why [Yahoo! Finance][Yahoo! Finance]
- Biogen (NASDAQ:BIIB) had its price target raised by analysts at Mizuho from $207.00 to $236.00. They now have an "outperform" rating on the stock.[MarketBeat]
- Biogen (NASDAQ:BIIB) was given a new $231.00 price target on by analysts at Wolfe Research.[MarketBeat]
- Biogen (NASDAQ:BIIB) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..[MarketBeat]
- More
BIIB
SEC Filings
SEC Filings
- 2/17/26 - Form 4
- 2/17/26 - Form 4
- 2/17/26 - Form 4
- BIIB's page on the SEC website
- More